HIGHLIGHTS
- who: Plasma Asymmetric Dimethylarginine and colleagues from the University, Taipei, Taiwan, Division of Cardiology, University Hospital, Lan, Taiwan, Division of Cardiology, Department of have published the research: Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram, in the Journal: PLOS ONE | www.plosone.org of January/24,/2013
- what: The aim of this study was to investigate whether the levels of ADMA are a predictor of poor clinical outcomes in patients with AF.
- how: The Mann-Whitney rank-sum test was used for the analysis of skewed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.